Literature DB >> 1909137

Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells.

G Soldevila1, M Buscema, M Doshi, R F James, G F Bottazzo, R Pujol-Borrell.   

Abstract

We have previously reported that the combination of IFN-gamma plus TNF-alpha is able to induce the de novo expression of HLA class II on human beta cells. In the present study, we have investigated the effect of these cytokines, alone or in combination, on the function and viability of human islet cells in vitro. Three hour insulin release was markedly reduced in human islet monolayer cultures after 4 days' exposure to 1000 U/ml of the combination TNF-alpha plus IFN-gamma (36.7 +/- 7.7, % of the control +/- SEM) or to TNF-alpha alone (49.5 +/- 7% of the control) while IFN-gamma had little effect. On direct inspection cell damage was clearly detected only in the cultures treated with TNF-alpha plus IFN-gamma in which staining by indirect immunofluorescence (IFL) for insulin revealed that the number of beta cells was also significantly reduced, thus suggesting a real cytotoxic effect of this cytokine combination. This effect was not beta cell specific since glucagon release and the number of alpha cells were also reduced in the cultures exposed to IFN-gamma plus TNF-alpha. 51Cr release experiments supported the cytoxicity of these cytokines to normal islet cells. There was a time course relationship between class II induction (2 days) and the cytotoxic effect of IFN-gamma plus TNF-alpha (4 days) on the same islet cells. In conclusion, these results indicate that the combination of IFN-gamma and TNF-alpha exerts a cytotoxic effect on human islet cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909137     DOI: 10.1016/0896-8411(91)90025-8

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

1.  Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis.

Authors:  Danny Hung-Chieh Chou; Edward B Holson; Florence F Wagner; Alicia J Tang; Rebecca L Maglathlin; Timothy A Lewis; Stuart L Schreiber; Bridget K Wagner
Journal:  Chem Biol       Date:  2012-06-22

2.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Authors:  D L Eizirik; S Sandler; N Welsh; M Cetkovic-Cvrlje; A Nieman; D A Geller; D G Pipeleers; K Bendtzen; C Hellerström
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.

Authors:  M J Hussain; M Peakman; H Gallati; S S Lo; M Hawa; G C Viberti; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Sensitivity profile of the human EndoC-βH1 beta cell line to proinflammatory cytokines.

Authors:  Ewa Gurgul-Convey; Ilir Mehmeti; Thomas Plötz; Anne Jörns; Sigurd Lenzen
Journal:  Diabetologia       Date:  2016-07-27       Impact factor: 10.122

6.  Impact of metabolic activity of beta cells on cytokine-induced damage and recovery of rat pancreatic islets.

Authors:  A Dunger; D Schröder; P Augstein; T Witstruck; G Wachlin; L Vogt; B Ziegler; S Schmidt
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

7.  Small-Molecule Suppressors of Cytokine-Induced beta-Cell Apoptosis.

Authors:  Danny Hung-Chieh Chou; Nicole E Bodycombe; Hyman A Carrinski; Timothy A Lewis; Paul A Clemons; Stuart L Schreiber; Bridget K Wagner
Journal:  ACS Chem Biol       Date:  2010-08-20       Impact factor: 5.100

Review 8.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

Review 9.  Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines.

Authors:  Yaíma L Lightfoot; Jing Chen; Clayton E Mathews
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

10.  A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes.

Authors:  Xi Wang; Kristina G Maxwell; Kai Wang; Daniel T Bowers; James A Flanders; Wanjun Liu; Long-Hai Wang; Qingsheng Liu; Chengyang Liu; Ali Naji; Yong Wang; Bo Wang; Jing Chen; Alexander U Ernst; Juan M Melero-Martin; Jeffrey R Millman; Minglin Ma
Journal:  Sci Transl Med       Date:  2021-06-02       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.